Showing results (111-120 of 120) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 InhibitionKevin Shee, Jason D Wells, Matthew Ung, et al.Mabs|August 26, 2016
Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CAJames W Larrick, Mark R Alfenito, Jamie K Scott, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast CancerNicole A Traphagen, Gary N Schwartz, Steven Tau, et al.Cancer Research|January 8, 2025
Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast CancerSteven Tau, Mary D Chamberlin, Huijuan Yang, et al.Breast Cancer Research and Treatment|June 21, 2020
Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancerMary D Chamberlin, Jason D Wells, Kevin Shee, et al.Cancer Discovery|November 4, 2011
ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancerTodd W Miller, Justin M Balko, Emily M Fox, et al.Nature Medicine|June 12, 2012
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistanceJustin M Balko, Rebecca S Cook, David B Vaught, et al.The Oncologist|July 25, 2015
Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical CenterLaura J Tafe, Ivan P Gorlov, Francine B de Abreu, et al.Proceedings of the National Academy of Sciences of the United States of America|February 25, 2018
Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapyKonstantinos V Floros, Timothy L Lochmann, Bin Hu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2020
Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast CancerMargaret L Axelrod, Mellissa J Nixon, Paula I Gonzalez-Ericsson, et al.Pageof 12